Akeso Biopharma

Photo of a person celebrating at the top of the mountain while the sun setsrises

Biotech

Akeso's bispecific notches ph. 3 victory against gastric cancer

Akeso's lead bispecific antibody has notched a critical phase 3 victory as the biotech looks to burst open the drug's usage.

Max Bayer Nov 7, 2023 10:50am

mountain top climb

Summit bets $5B that Akeso's bispecific will reach cancer peak

Dec 6, 2022 12:50pm